Molecular classification of the PORTEC-3 trial for high-risk endometrial cancer: impact on prognosis and benefit from adjuvant therapy

  • Authors:
  • et al.
  • TransPORTEC consortium

Researchers

  1. Edmondson, Richard

    Person: Academic (Staff)

Return to publication overview